NP202 for Treatment of Post -STEMI Left Ventricular Systolic Dysfunction

Clinical trial NCT02557217 · UNKNOWN

Trial details

NCT number: NCT02557217
Sponsor: Armaron Bio Pty Ltd
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

ST Elevation Myocardial Infarction

Start date: 2015-10-01
Primary completion: 2017-12-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.